China Health Group Limited (HKG:0673)
Hong Kong · Delayed Price · Currency is HKD 0.3050
0.00 (0.00%)
Sep 28, 2026, 1:09 PM HKT
China Health Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 423 | 721 | 117 | 455 | 536 | 211 | |
Market Cap Growth | 42.35% | 519.05% | -74.39% | -15.18% | 154.09% | -13.56% |
Enterprise Value | 409 | 672 | 127 | 464 | 562 | 212 |
Last Close Price | 0.30 | 0.52 | 0.19 | 0.76 | 0.90 | 0.41 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PS Ratio | 10.30 | 17.55 | 2.99 | 7.59 | 7.02 | 1.97 |
PB Ratio | 6.95 | 11.86 | 1226.52 | 7.62 | 5.71 | 2.48 |
P/TBV Ratio | 10.15 | 17.31 | - | 19.36 | 11.62 | 5.88 |
P/FCF Ratio | - | - | - | - | - | 6.78 |
P/OCF Ratio | - | - | - | - | - | 6.61 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 9.96 | 16.35 | 3.27 | 7.74 | 7.36 | 1.98 |
EV/EBITDA Ratio | - | - | - | 142.80 | - | - |
EV/EBIT Ratio | - | - | - | 1233.16 | - | - |
EV/FCF Ratio | - | - | - | - | - | 6.81 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.08 | 0.08 | 68.44 | 0.10 | 0.06 | 0.22 |
Debt / EBITDA Ratio | - | - | - | 1.15 | - | - |
Debt / FCF Ratio | - | - | - | - | - | 0.59 |
Net Debt / Equity Ratio | -0.35 | -0.35 | 9.90 | 0.03 | -0.12 | 0.11 |
Net Debt / EBITDA Ratio | 0.66 | 0.66 | -0.02 | 0.51 | 1.16 | -1.13 |
Net Debt / FCF Ratio | 0.25 | 0.25 | -0.11 | -0.23 | 0.56 | 0.30 |
Asset Turnover | 0.27 | 0.27 | 0.23 | 0.29 | 0.34 | 0.48 |
Inventory Turnover | 2.72 | 2.72 | 1.85 | 3.06 | 3.92 | 8.46 |
Quick Ratio | 0.83 | 0.83 | 0.47 | 0.30 | 0.44 | 0.44 |
Current Ratio | 1.24 | 1.24 | 0.87 | 1.15 | 1.12 | 1.01 |
Return on Equity (ROE) | -158.94% | -158.94% | -226.64% | -55.30% | -44.18% | -9.85% |
Return on Assets (ROA) | -13.94% | -13.94% | -15.85% | 0.11% | -3.58% | -3.18% |
Return on Capital Employed (ROCE) | -55.90% | -55.90% | -279.90% | 0.50% | -13.60% | -12.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -11.33% | -6.64% | -58.18% | -8.83% | -7.84% | -5.78% |
FCF Yield | -20.36% | -11.94% | -7.17% | -1.54% | -3.91% | 14.75% |
Buyback Yield / Dilution | -60.43% | -60.43% | -26.77% | -11.46% | -3.48% | - |